These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 18076548)

  • 21. Genotypic and phenotypic characterization of Trypanosoma brucei gambiense isolates from Ibba, South Sudan, an area of high melarsoprol treatment failure rate.
    Maina N; Maina KJ; Mäser P; Brun R
    Acta Trop; 2007; 104(2-3):84-90. PubMed ID: 17765860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gambian trypanosomiasis and synergism between melarsoprol and eflornithine: first case report.
    Simarro PP; Asumu PN
    Trans R Soc Trop Med Hyg; 1996; 90(3):315. PubMed ID: 8758090
    [No Abstract]   [Full Text] [Related]  

  • 23. Human African trypanosomiasis with 7-year incubation period: clinical, laboratory and neuroimaging findings.
    Wengert O; Kopp M; Siebert E; Stenzel W; Hegasy G; Suttorp N; Stich A; Zoller T
    Parasitol Int; 2014 Jun; 63(3):557-60. PubMed ID: 24613272
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Magnetic resonance imaging findings in human African trypanosomiasis: a four-year follow-up study in a patient and review of the literature.
    Kager PA; Schipper HG; Stam J; Majoie CB
    Am J Trop Med Hyg; 2009 Jun; 80(6):947-52. PubMed ID: 19478256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo evaluation of sixteen plant extracts on mice inoculated with Trypanosoma brucei gambiense.
    Youan BB; Coulibaly S; Miezan TB; Doua F; Bamba M
    Bull World Health Organ; 1997; 75(4):343-8. PubMed ID: 9342893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Agents for the treatment of African sleeping sickness. Those developed in the last century].
    Schlitzer M
    Pharm Unserer Zeit; 2009; 38(6):552-8. PubMed ID: 19862727
    [No Abstract]   [Full Text] [Related]  

  • 27. Cardiac involvement in African and American trypanosomiasis.
    Blum JA; Zellweger MJ; Burri C; Hatz C
    Lancet Infect Dis; 2008 Oct; 8(10):631-41. PubMed ID: 18922485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiac alterations in human African trypanosomiasis (T.b. gambiense) with respect to the disease stage and antiparasitic treatment.
    Blum JA; Schmid C; Burri C; Hatz C; Olson C; Fungula B; Kazumba L; Mangoni P; Mbo F; Deo K; Mpanya A; Dala A; Franco JR; Pohlig G; Zellweger MJ
    PLoS Negl Trop Dis; 2009; 3(2):e383. PubMed ID: 19221604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Melarsoprol-free drug combinations for second-stage Gambian sleeping sickness: the way to go.
    Chappuis F
    Clin Infect Dis; 2007 Dec; 45(11):1443-5. PubMed ID: 17990226
    [No Abstract]   [Full Text] [Related]  

  • 30. Eflornithine is a cost-effective alternative to melarsoprol for the treatment of second-stage human West African trypanosomiasis in Caxito, Angola.
    Robays J; Raguenaud ME; Josenando T; Boelaert M
    Trop Med Int Health; 2008 Feb; 13(2):265-71. PubMed ID: 18304274
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Control of human African trypanosomiasis in the Quiçama focus, Angola.
    Ruiz JA; Simarro PP; Josenando T
    Bull World Health Organ; 2002; 80(9):738-45. PubMed ID: 12378293
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Melarsoprol].
    Simon F
    Med Trop (Mars); 1999; 59(4):331-2. PubMed ID: 10816741
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical aspects of 2541 patients with second stage human African trypanosomiasis.
    Blum J; Schmid C; Burri C
    Acta Trop; 2006 Jan; 97(1):55-64. PubMed ID: 16157286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Eflornithine for African sleeping sickness.
    Sjoerdsma A; Schechter PJ
    Lancet; 1999 Jul; 354(9174):254. PubMed ID: 10421331
    [No Abstract]   [Full Text] [Related]  

  • 35. [Psychiatric presentation of human African trypanosomiasis: overview of diagnostic pitfalls, interest of difluoromethylornithine treatment and contribution of magnetic resonance imaging].
    Bédat-Millet AL; Charpentier S; Monge-Strauss MF; Woimant F
    Rev Neurol (Paris); 2000 May; 156(5):505-9. PubMed ID: 10844370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Sleeping sickness from early diagnosis to post-therapy follow-up].
    Wery M
    Bull Mem Acad R Med Belg; 1986; 141(2):203-12. PubMed ID: 3533186
    [No Abstract]   [Full Text] [Related]  

  • 37. Human African trypanosomiasis: diagnosis, relapse and survival after severe melarsoprol-induced encephalopathy.
    Checkley AM; Pepin J; Gibson WC; Taylor MN; Jäger HR; Mabey DC
    Trans R Soc Trop Med Hyg; 2007 May; 101(5):523-6. PubMed ID: 17270227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-effectiveness analysis of alternative treatments of African gambiense trypanosomiasis in Uganda.
    Politi C; Carrín G; Evans D; Kuzoe FA; Cattand PD
    Health Econ; 1995; 4(4):273-87. PubMed ID: 8528430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The sleep-wake cycle during Trypanosoma brucei rhodesiense human African trypanosomiasis in 2 French parachutists].
    Montmayeur A; Brosset C; Imbert P; Buguet A
    Bull Soc Pathol Exot; 1994; 87(5):368-71. PubMed ID: 7496202
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trypanosomiasis, cardiomyopathy and the risk of ischemic stroke.
    Carod-Artal FJ
    Expert Rev Cardiovasc Ther; 2010 May; 8(5):717-28. PubMed ID: 20450304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.